Ophthalmic Product definition

Ophthalmic Product means any product containing an Ophthalmic Candidate, or in the case of the [***], a cell-based product generated through genetic modification using an Ophthalmic Candidate.
Ophthalmic Product means any product in final dosage form for commercial sale by prescription, over-the-counter, or by any other method (or, where the context so indicates, the product being tested in clinical trials), incorporating Compound as the primary therapeutically active ingredient in a liquid pharmaceutical formulation that is applied directly to the eyes, such Ophthalmic Product to include a combination product with other chemically or biologically active components.
Ophthalmic Product means an RNAi Product which is directed at a Program Target, that is (a) contributed by a Party to a Program in the Ophthalmic Collaboration, including without limitation, the Ophthalmic Product(s) identified on Schedule 2.3, or (b) discovered, derived or developed by a Party or any person or entity acting on behalf of a Party, including Affiliates, consultants and scientific advisors thereof, in the course of the Ophthalmic Collaboration, including, without limitation, any Combination Product, Profit-Sharing Product and/or Royalty-Bearing Product.

Examples of Ophthalmic Product in a sentence

  • Subject to Article 8 (Manufacturing and Technology Transfer), NVS will use Commercially Reasonable Efforts to Develop and obtain Marketing Approval for at least [***] Product in each of the In-Vivo Field and Ex-Vivo Field and for at least [***] Ophthalmic Product that Modulates each Ophthalmic Target.

  • KR shall promptly notify MN upon the receipt of Regulatory Approvals and of the date of first commercial sale of (i) Ophthalmic Product in the KR Territory or the MN Territory, (ii) Compound and/or Licensed Product for the Optional Indications in the MN Territory or the KR Territory, or (iii) Compound or Licensed Product for the MS Indication in the KR Territory.

  • By: /s/ Xxxxxxx Xxxxxx --------------------------- APPENDIX A SPECIFICATIONS Glass Code 8013 Corning Incorporated North American Optical division Ophthalmic Product Specifications No. OPS-54, issued 2/01/89, applies to the control of quality of standard fixed tint lens pressings intended for sunglass lenses.

  • No later than [**] prior to expiration of the Pre-Clinical Development Collaboration Term, the Parties, through the JSC, shall discuss any Ophthalmic Products that are not Royalty-Bearing Products and have not yet advanced to the Pre-IND Filing Opt-Out Period and shall mutually agree which Party shall be the Continuing Party for such Ophthalmic Product.

  • If a compulsory license is granted to a Third Party with respect to an Ophthalmic Product in any country in the Territory with a royalty rate lower than the applicable royalty rate set forth in this Section 8.3, then the royalty rate to be paid by the Royalty Payor on Net Sales in that country under this Section 8.3 shall be reduced to the rate paid by the compulsory licensee.

  • The Parties acknowledge that during the Agreement Term, a Royalty Payor's sales practices for the marketing and distribution of an Ophthalmic Product may change to the extent to which the calculation of the payment for royalties on Net Sales may become impractical or even impossible.

  • Subject to Article 8 (Manufacturing and Technology Transfer), NVS will use Commercially Reasonable Efforts to Develop and obtain Marketing Approval for at least [***] Sickle Cell Product in each of the In-Vivo Field and Ex-Vivo Field and for at least [***] Ophthalmic Product that Modulates each Ophthalmic Target.

  • Each Ophthalmic Product being jointly Developed and Commercialized by the Parties under this Agreement shall be referred to as a "Profit-Sharing Product", unless and until a Party exercises its Opt-Out Rights with respect to such Profit-Sharing Product.

  • Following the expiration of the Pre-Clinical Development Collaboration Term, such Ophthalmic Product shall be deemed a Royalty-Bearing Product under this Agreement.

  • Inspire shall use reasonable efforts to cooperate with Faes to provide, at Faes’ expense, all reasonable assistance reasonably requested by Faes that are necessary for Faes to comply with any law applicable to any Faes Non-Ophthalmic Product or Faes Licensed Ophthalmic Product, including reporting of adverse drug experience reports (and serious adverse drug experiences) to Regulatory Authorities in the applicable countries.

Related to Ophthalmic Product

  • Diagnostic Product means any test or assay for diagnosing or detecting a disease, disorder, medical condition, or symptom.

  • Generic Product means a product which (a) contains as its active pharmaceutical ingredient a compound that is (or is substantially the same as) the Licensed Compound, and (b) has been placed on the market pursuant to a validly granted marketing authorization.

  • Licensed Product means any pharmaceutical product containing a Licensed Compound (alone or with other active ingredients), in all forms, presentations, formulations and dosage forms.

  • Hemp product means the same as that term is defined in § 3.2-4112.

  • medicinal product means any substance or combination of substances presented for treating or preventing disease in human beings or animals and any substance or combination of substances which may be administered to human beings or animals with a view to making a medical diagnosis or to restoring, correcting or modifying physiological functions in humans or in animals;

  • Cannabis product means cannabis that has undergone a process whereby the plant material has been transformed into a concentrate, including, but not limited to, concentrated cannabis, or an edible or topical product containing cannabis or concentrated cannabis and other ingredients.

  • Tobacco product means any substance containing tobacco leaf, including but not limited to, cigarettes, cigars, pipe tobacco, hookah tobacco, snuff, chewing tobacco, dipping tobacco, bidis, blunts, clove cigarettes, or any other preparation of tobacco; and any product or formulation of matter containing biologically active amounts of nicotine that is manufactured, sold, offered for sale, or otherwise distributed with the expectation that the product or matter will be introduced into the human body by inhalation; but does not include any cessation product specifically approved by the U.S. Food and Drug Administration for use in treating nicotine or tobacco dependence.

  • Collaboration Product means any pharmaceutical product in finished form that contains a Collaboration Compound, either as the sole active ingredient or in combination with one or more other active ingredients, and all present and future formulations, dosages and dosage forms thereof.

  • Licensed Products means tangible materials which, in the course of manufacture, use, sale, or importation, would be within the scope of one or more claims of the Licensed Patent Rights that have not been held unpatentable, invalid or unenforceable by an unappealed or unappealable judgment of a court of competent jurisdiction.

  • Licensed Compound means [***].

  • Nicotine product means a product that contains nicotine and is not any of the following:

  • Biological product means a virus, therapeutic serum, toxin, antitoxin, vaccine, blood, blood component or derivative, allergenic product, protein other than a chemically synthesized polypeptide, or analogous product, or arsphenamine or any derivative of arsphenamine or any other trivalent organic arsenic compound, applicable to the prevention, treatment, or cure of a disease or condition of human beings.

  • Drug Product means a specific drug in dosage form from a known source of manufacture, whether

  • Licensed Compounds means any EZH2 Compound(s) that is:

  • Licensed Field means all fields of use.

  • New Product means the Synology-branded hardware product and Synology-branded accessories contained in the original packaging Customer bought from an authorized Synology distributor or reseller. You may see our “New Product” at Product Support Status.

  • Cannabis products means cannabis that has undergone a process whereby the plant material has been transformed into a concentrate, including, but not limited to, concentrated cannabis, or an edible or topical product containing cannabis or concentrated cannabis and other ingredients.